Related Experiment Video
Updated: Feb 25, 2026

Modeling Posthemorrhagic Hydrocephalus of Prematurity in Rats
Published on: March 28, 2025
Health Care Expenditures and Utilization for Children With Noncomplex Chronic Disease
Erik R Hoefgen1, Annie L Andrews2, Troy Richardson3
1Division of Hospital Medicine, Cincinnati Children's Hospital Medical Center and Department of Pediatrics, College of Medicine, University of Cincinnati, Cincinnati, Ohio; erik.hoefgen@cchmc.org.
Insights
Children with noncomplex chronic diseases (NC-CDs) represent a significant portion of pediatric Medicaid spending, costing $2801 per member per year. Their healthcare utilization and costs are substantially higher than those without chronic conditions.
Area of Science:
- Pediatric Health Economics
- Healthcare Management
- Public Health Policy
Background:
- Pediatric healthcare expenditures vary significantly based on illness complexity and chronicity.
- Understanding costs associated with noncomplex chronic diseases (NC-CDs) in children is crucial for resource allocation.
Purpose of the Study:
- To determine the healthcare expenditures and utilization patterns for children with NC-CDs within the Medicaid population.
- To compare these expenditures and utilization against children without chronic diseases (WO-CDs) and those with complex chronic diseases (C-CDs).
Main Methods:
- Retrospective, cross-sectional analysis of Medicaid enrollees (ages 0-18) from 2012-2013.
- Utilized Truven MarketScan Medicaid Database administrative claims.
- Categorized patients into WO-CDs (CRG 1-2), NC-CDs (CRG 3-5), and C-CDs (CRG 6-9) using 3M Clinical Risk Groups (CRGs).
Main Results:
- Children with NC-CDs constituted 36% of the pediatric population studied.
- NC-CDs accounted for 33% of annual spending ($2801 PMPY), significantly more than WO-CDs ($1151 PMPY).
- Median outpatient visits over 2 years were 15 for NC-CDs, compared to 8 for WO-CDs and 34 for C-CDs.
Conclusions:
- Children with NC-CDs incur substantially higher per-member-per-year and aggregate annual expenditures than children without chronic diseases.
- The significant societal cost of NC-CDs in children, estimated at ~$34.9 billion annually in national Medicaid spending, warrants attention.
- Targeted interventions for NC-CDs could optimize pediatric healthcare resource allocation and reduce overall costs.
Background:
Pediatric health care expenditures and use vary by level of complexity and chronic illness. We sought to determine expenditures and use for children with noncomplex chronic diseases (NC-CDs).
Methods:
We performed a retrospective, cross-sectional analysis of Medicaid enrollees (ages 0-18 years) from January 1, 2012, through December 31, 2013, using administrative claims (the Truven MarketScan Medicaid Database). Patients were categorized by chronicity of illness by using 3M Health Information System's Clinical Risk Groups (CRGs) as follows: without chronic diseases (WO-CDs) (CRG 1-2), NC-CDs (CRG 3-5), and complex chronic diseases (C-CDs) (CRG 6-9). Primary outcomes were medical expenditures, including total annualized population expenditure and per-member per-year expenditure (PMPY). Secondary outcomes included the number of health care encounters over the 2-year period.
Results:
There were 2 424 946 children who met inclusion criteria, 53% were WO-CD; 36% had an NC-CD; and 11% had a C-CD. Children with NC-CDs accounted for 33% ($2801 PMPY) of the annual spending compared with 20% ($1151 PMPY) accounted for by children WO-CDs and 47% ($12 569 PMPY) by children with C-CDs. The median outpatient visit count by group over the 2-year period was 15 (interquartile range [IQR] 10-25) for NC-CD, 8 (IQR 5-13) WO-CD, and 34 (IQR 19-72) for C-CD.
Conclusions:
Children with NC-CDs accounted for 33% of pediatric Medicaid expenditures and have significantly higher PMPY and aggregate annual expenditures than children WO-CDs. The annual aggregate expenditures of the NC-CD group represent a significant societal cost because of the high volume of children, extrapolated to ∼$34.9 billion annually in national Medicaid expenditures.
More Related Videos
05:56Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
08:13Development and Implementation of a Multi-Disciplinary Technology Enhanced Care Pathway for Youth and Adults with Concussion
Published on: January 20, 2019
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Drug Dosing: Infants and Children
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Methods Of Healthcare Delivery System
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
Pharmacokinetics in Pediatric Patients: Drug Distribution
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic...